Dabigatran Etexilate
Top Cited Papers
- 5 April 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 123 (13) , 1436-1450
- https://doi.org/10.1161/circulationaha.110.004424
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- New AnticoagulantsCirculation, 2010
- Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran EtexilateClinical Pharmacokinetics, 2010
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic DataNew England Journal of Medicine, 2009
- Pharmacology and Management of the Vitamin K AntagonistsChest, 2008
- Pharmacokinetics and Pharmacodynamics of the Direct Oral Thrombin Inhibitor Dabigatran in Healthy Elderly SubjectsClinical Pharmacokinetics, 2008
- Clinical Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin??Inhibitor Dabigatran EtexilateClinical Pharmacokinetics, 2008
- The direct thrombin inhibitor ximelagatran/melagatran: a systematic review on clinical applications and an evidence based assessment of risk benefit profileExpert Opinion on Drug Safety, 2007
- The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjectsBritish Journal of Clinical Pharmacology, 2007
- Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: a population model analysisBritish Journal of Clinical Pharmacology, 2006
- Use and Effectiveness of Warfarin in Medicare Beneficiaries With Atrial FibrillationStroke, 2006